These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12383006)

  • 41. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new serotonin 5-HT
    González-Vera JA; Medina RA; Martín-Fontecha M; Gonzalez A; de la Fuente T; Vázquez-Villa H; García-Cárceles J; Botta J; McCormick PJ; Benhamú B; Pardo L; López-Rodríguez ML
    Sci Rep; 2017 Jan; 7():41293. PubMed ID: 28117458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.
    Lemaître S; Lepailleur A; Bureau R; Butt-Gueulle S; Lelong-Boulouard V; Duchatelle P; Boulouard M; Dumuis A; Daveu C; Lezoualc'h F; Pfeiffer B; Dauphin F; Rault S
    Bioorg Med Chem; 2009 Mar; 17(6):2607-22. PubMed ID: 19261477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.
    Moritomo A; Yamada H; Watanabe T; Itahana H; Koga Y; Akuzawa S; Okada M
    Bioorg Med Chem; 2014 Aug; 22(15):4323-37. PubMed ID: 24916029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3D QSAR based design of novel oxindole derivative as 5HT7 inhibitors.
    Chitta A; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2014 Jun; 34(3):185-94. PubMed ID: 24456291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
    Vermeulen ES; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2003 Dec; 46(25):5365-74. PubMed ID: 14640545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
    J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Giorgi G; Ghelardini C; Collina S
    Bioorg Med Chem; 2002 Mar; 10(3):779-801. PubMed ID: 11814868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular design based on 3D-pharmacophore. Application to 5-HT4 receptor.
    Bureau R; Daveu C; Lemaître S; Dauphin F; Landelle H; Lancelot JC; Rault S
    J Chem Inf Comput Sci; 2002; 42(4):962-7. PubMed ID: 12132898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
    Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
    J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New benzimidazole derivatives: selective and orally active 5-HT3 receptor antagonists.
    Pascual D; Girón R; Alsasua A; Benhamú B; López-Rodríguez ML; Martín MI
    Eur J Pharmacol; 2003 Feb; 462(1-3):99-107. PubMed ID: 12591101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
    Zeng H; Zhang H; Jang F; Zhao L; Zhang J
    Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity.
    Pérez-Villanueva J; Medina-Franco JL; Caulfield TR; Hernández-Campos A; Hernández-Luis F; Yépez-Mulia L; Castillo R
    Eur J Med Chem; 2011 Aug; 46(8):3499-508. PubMed ID: 21621311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, biological evaluation and binding mode modeling of benzimidazole derivatives targeting the cannabinoid receptor type 1.
    Espinosa-Bustos C; Lagos CF; Romero-Parra J; Zárate AM; Mella-Raipán J; Pessoa-Mahana H; Recabarren-Gajardo G; Iturriaga-Vásquez P; Tapia RA; Pessoa-Mahana CD
    Arch Pharm (Weinheim); 2015 Feb; 348(2):81-8. PubMed ID: 25641513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.